Should ventilation tubes be removed or retained during pediatric cochlear implantation? Study sheds light

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-01-20 14:30 GMT   |   Update On 2023-01-20 14:30 GMT

Japan: The insertion of a ventilation tube (VT) is usually recommended before cochlear implantation (CI) in pediatric cochlear implant candidates with recurrent acute otitis media (AOM) or chronic otitis media with effusion (OME). However, there is no consensus on whether VT is beneficial even after the implantation or whether the tube should be removed or retained during cochlear implantation.

Hiroshi Yamazaki, Kobe City Medical Center General Hospital, Kobe City, Japan, and colleagues, therefore, aimed to evaluate the effect of tube placement following CI, particularly on the incidence of post-CI AOM, in children recipient of cochlear implant who had undergone VT insertion before cochlear implantation because of recurrent AOM or chronic OME in a retrospective medical record review.

Advertisement

The study, published in Otology & Neurotology, suggests that retaining the tube in position rather than removing it may decrease the incidence of acute otitis media at least six months after cochlear implantation in CI for children who already have a VT because of a recurrent AOM or chronic OME.

The researchers recruited 58 consecutive ears of children who underwent the insertion of a ventilation tube followed by cochlear implantation at age seven years or younger between 2004 and 2021. Before 2018, the team removed the VT simultaneously with CI (removed groups, 39 ears), and the tube, since then, has remained in place during CI (retained group, 19 ears).

The proportion of ears that developed acute otitis media at post-CI six months in the removed and retained groups was determined (primary outcome).

The authors reported the following findings:

· The age at CI was significantly higher in the removed group than in the retained group (mean: the removed group, 2.9 yr; the retained group: 1.5 yr).

· The removed group showed a remarkably higher proportion of ears with post-CI AOM (8 of 39 ears; 20.5%) than the retained group (none of 19 ears; 0%) 6 months after CI.

· The AOM-free proportion at post-CI 12 months was 76.9% in the removed group and 83.3% in the retained group, demonstrating no significant difference, probably because the VT was spontaneously extruded in the retained group at a median of 6.5 months after CI.

· Throughout the study period, 17 ears (13 from the removed group) were affected by post-CI AOM. Of these, three ears in the removed group and two in the retained group after spontaneous extrusion of the VT were hospitalized and treated with intravenous antibiotics for AOM that had failed to respond to oral antibiotic therapy.

· Only one ear in the removed group required an explanation of the infected implant.

· None suffered from chronic tympanic membrane perforation or secondary cholesteatoma after VT insertion or meningitis associated with post-CI AOM.

"Our findings indicate that in cochlear implantation for children who already have a ventilation tube because of a recurrent AOM, or chronic AOM, leaving the tube in position, rather than its removal, may reduce AOM incidence at least within six months after the cochlear implantation, during which most infections from cochlear implant was reported in the pediatric population," the authors concluded.

Reference:

Tobe, Yota∗; Yamazaki, Hiroshi∗†‡§; Shirakawa, Chigusa∥; Shinohara, Shogo∗; Fujiwara, Keizo∗†; Naito, Yasushi∗†. Management of Already Inserted Ventilation Tubes During Pediatric Cochlear Implantation: To Remove or Leave the Tube?. Otology & Neurotology ():10.1097/MAO.0000000000003797, January 5, 2023. | DOI: 10.1097/MAO.0000000000003797


Tags:    
Article Source : Otology & Neurotology

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News